Neurocrine Biosciences, Inc. (NBIX) vs Repligen Corporation (RGEN)
Detailed comparison between Neurocrine Biosciences, Inc., Repligen Corporation.Total Return (%)
Neurocrine Biosciences, Inc. (NBIX)Repligen Corporation (RGEN)
Which stock do you think will perform better?
Neurocrine Biosciences, Inc.
NBIX
Repligen Corporation
RGEN
| Metric | Neurocrine Biosciences, Inc. (NBIX) | Repligen Corporation (RGEN) |
|---|---|---|
| Current Price | $116.87 | $131.55 |
| Change | -3.56 (-2.96%) | -2.17 (-1.62%) |
| Market Cap | $11.57B | $7.39B |
| Trailing P/E | 39.62 | 0.00 |
| Forward P/E | 18.82 | 73.90 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $157.98 | $182.52 |
| 52-Week Low | $84.23 | $102.97 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $2.95 | $-0.41 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| NBIX | 21.54% | -18.02% | -17.70% | 0.32% | 180.74% | 178.66% |
| RGEN | 3.89% | -16.36% | -25.27% | -6.36% | 216.00% | 217.98% |